http://sierraworldequityreview.blogspot.com/2014/08/behind-scenesastrazeneca-azn-to-buyout.html True???
its cheap now anyway!! Why Galena Biopharma Inc. Stock Tumbled By Sean Williams August 12, 2014 What: Shares of Galena Biopharma (NASDAQ: GALE ) , a biopharmaceutical company focused on developing immunotherapies to treat cancer, tumbled by as much as 16% after the company reported its second-quarter earnings results. So what: For the quarter, Galena reported $2.3 million in revenue from Abstral, its cancer pain medication acquired from Orexo last year, compared to no revenue recorded in the year-ago period. Operating loss, however, ballooned to $15.8 million, including stock-based compensation charges, from $11.8 million in the year-ago quarter. On a per share basis this worked out to a loss of $0.17 when Wall Street was looking for a much narrower loss of $0.09 per share. Galena ended the quarter with $39.2 million in cash, which is down from $47.8 million as of the end of December. Now what: Usually earning…
